Pfizer Inc. (PFE) Return on equity 2016–2025
Pfizer Inc. (PFE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
9.0%FY2025 · since FY2016: 12.1% → 9.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.0% | -0.1 pp |
| FY2024 | 9.1% | +6.7 pp |
| FY2023 | 2.4% | -30.4 pp |
| FY2022 | 32.8% | +4.3 pp |
| FY2021 | 28.5% | +14.0 pp |
| FY2020 | 14.5% | -10.9 pp |
| FY2019 | 25.4% | +7.8 pp |
| FY2018 | 17.6% | -12.3 pp |
| FY2017 | 29.9% | +17.8 pp |
| FY2016 | 12.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice